This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seyedehmina Rafieishishavan: Innovator in Cell Culture Control
Introduction
Seyedehmina Rafieishishavan is a notable inventor based in Windsor, California. He has made significant contributions to the field of biotechnology, particularly in the area of cell culture processes. His innovative approach combines predictive modeling techniques to enhance the efficiency and control of cell culture systems.
Latest Patents
Seyedehmina holds a patent for a method titled "Hybrid predictive modeling for control of cell culture." This patent describes a sophisticated approach to managing cell culture processes through hybrid predictive modeling in a model predictive controller. The method involves obtaining current values of cell culture attributes and generating control values for physical inputs to the cell culture process. By predicting future values of these attributes using data-driven and first principle models, the method optimizes control values to improve the overall process.
Career Highlights
Seyedehmina is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to apply his expertise in predictive modeling to real-world applications, contributing to advancements in biopharmaceutical development.
Collaborations
Throughout his career, Seyedehmina has collaborated with talented professionals, including Mohammad Rashedi and Hamid Khodabandehlou. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Seyedehmina Rafieishishavan is a pioneering inventor whose work in hybrid predictive modeling has the potential to revolutionize cell culture processes. His contributions to biotechnology exemplify the importance of innovation in advancing scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
